Luis Alvarez/DigitalVision via Getty Images
OpenAI (OPENAI) CEO Sam Altman said his startup is considering investing in biotech and pharmaceutical firms that utilize artificial intelligence applications to discover new drugs or therapies, according to Bloomberg.
In return, OpenAI could receive royalties from the revenue generated by